As the most common cell type, more doctors have encountered epithelioid mesothelioma, and there is a more diverse range of cancer treatment options available. These factors tend to improve a patient’s life expectancy compared to other cell types of mesothelioma. 2. Sarcomatoid Mesothelioma The leas...
Different Treatment Options Available for Breast Cancer
A new study published today in theJournal of the National Cancer Instituteindicates that different therapies for early-stage breast cancer have very different relative values. Some therapies may have fewer complications and be much less expensive than others. Women may be making treatment decisions bas...
For Breast Cancer Awareness Month Kristina Mirabeau-Beale, mD, MPH, and Bridget Koontz, MD, discuss the different types of breast cancer that clinicians need to be aware of.
The main types of breast cancer are invasive ductal carcinoma, invasive lobular carcinoma, medullary carcinoma, Paget's disease...
Comparison of Different Surgical Options in the Treatment of Pilonidal Disease: Retrospective Analysis of 175 Patients Pilonidal sinus disease (PSD) is usually seen on the sacrococcygeal region in adolescent patients. The current study analyzed the outcome of the rhomboid e... OF Ersoy,HA Kayaoglu,...
In the following sections, the detailed treatment options for each type of breast cancer will be discussed. 2.1. Hormone-dependent breast cancer treatment Estrogen receptor-positive (ER+) breast cancer, integrated in the luminal A subtype, is the most common breast cancer subtype. In fact, about...
Although the prognosis of localised prostate cancer is good, the negative effects of prostate cancer treatment often impair patient quality of life. A growing number of men experience these negative effects over a longer time because of the increased incidence of and prolonged survival in prostate ca...
“For patients with MSI-H/dMMR colorectal cancer, KEYTRUDA monotherapy was approved in Europe as a first-line option in January 2021. Building on that approval, we are pleased that KEYTRUDA is now approved for the treatment of additional MSI-H/dMMR tumors, ...
Chief, Section of Hematology Banner MD Anderson Cancer Center Gilbert, AZ DISCUSSION QUESTIONS Have you utilized tafasitamab (Monjuvi) plus lenalidomide (Lenvima) for patients with diffuse large B-cell lymphoma (DLBCL) since its FDA approval? What has been your experience and your patients’ experi...